glp-1 drugs in development What is the pipeline for future medications for obesity? Emerging Trends in the Development
Description
REWIND found a 12% relative risk reduction in MACE (3-point major adverse cardiac events) with dulaglutide vs placebo ( [129] )
S.HueyE
Structural Insights into the Triple Agonism at GLP-1R, GIPR and GCGR Manifested by Retatrutide
Eat smaller, more frequent meals
Duan D, Kim LJ, Jun JC, Polotsky VY
What GLP-1 Is and Why Consumers Are Searching GLP-1, or glucagon-like peptide-1, is an incretin hormone produced naturally in the intestines after eating
